Stryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and Ankle
31 1월 2024 - 10:10PM
Business Wire
Stryker’s Footprint and Infinity Total Ankle System will be
featured at the American College of Foot and Ankle Surgeons Annual
Meeting
Stryker (NYSE: SYK), a global leader in medical technologies,
today announced the launch of Prophecy Footprint, an expansion of
the Prophecy Surgical Planning system, offering comprehensive
surgical planning across the entire foot. The system will be
demonstrated at the American College of Foot and Ankle Surgeons
(ACFAS) Annual Meeting, Tampa Bay, Fla., Feb. 1-4 (booth #919).
The launch of Prophecy Footprint also coincides with the tenth
anniversary of Stryker’s Infinity Total Ankle System, a low-profile
implant indicated for total ankle replacement in patients with
end-stage ankle arthritis. Since its launch in 2014, the Infinity
Total Ankle System has been featured in multiple studies, with the
largest series demonstrating 98.8% survivorship at the two-year
mark.1
"Our total ankle and enabling technology portfolios are an
incredible example of Stryker's legacy and its commitment to
surgeon-driven innovation and enhanced patient care," said Patrick
Fisher, vice president and general manager of Stryker’s Foot &
Ankle business. “Celebrating a decade of remarkable success,
Infinity continues to reflect our commitment to the highest levels
of performance. The latest addition to our enabling technology
portfolio, Prophecy Footprint, marks a significant milestone as one
of the first surgical planning systems that addresses the
complexities of the entire foot.” *
With 70% of patients receiving additional procedures at the time
of total ankle arthroplasty2, assessing the entire foot is
essential for understanding a patient-specific procedural approach.
Prophecy Footprint elevates surgical planning by providing
comprehensive procedural considerations that address concomitant
pathology at the time of total ankle arthroplasty.
“Prophecy Footprint offers surgeons more detailed and
comprehensive planning capabilities, especially crucial in complex
ankle arthroplasty cases," said Dr. Hodges Davis, medical director
for Stryker’s Foot and Ankle business. “It enables a more
integrated approach and facilitates a more complete view of the
foot around the ankle, enhancing the surgical planning experience
for surgeons and, as always, the ultimate goal is better clinical
outcomes for our patients.”
Prophecy Surgical Planning system’s history of innovation and
success includes:
- Over 60,000 ankle procedures planned globally since 20123
- Achieving 100% post-op neutral alignment4
- Saving an average of 38 minutes in the OR5
- Delivering an average of $2,500 in cost savings6
Stryker’s Foot & Ankle business will be showcasing Prophecy
Footprint at the ACFAS meeting. The event will feature an engaging
didactic session titled “Advancements in Surgical Planning for
Total Ankle Replacement,” led by Dr. Davis and Randy Clements, DPM,
that will explore how Prophecy Footprint provides insights into
potential ancillary procedures, contributing to the success of
total ankle replacements.7
About Stryker
Stryker is a global leader in medical technologies and, together
with its customers, is driven to make healthcare better. The
company offers innovative products and services in MedSurg,
Neurotechnology, Orthopaedics and Spine that help improve patient
and healthcare outcomes. Alongside its customers around the world,
Stryker impacts more than 130 million patients annually. More
information is available at www.stryker.com.
A surgeon must always rely on his or her own professional
clinical judgment when deciding whether to use a particular product
when treating a particular patient. Stryker does not dispense
medical advice and recommends that surgeons be trained in the use
of any particular product before using it in surgery.
The information presented is intended to demonstrate the breadth
of Stryker’s product offerings. A surgeon must always refer to the
package insert, product label and/or instructions for use before
using any of Stryker’s products. Products may not be available in
all markets because product availability is subject to the
regulatory and/or medical practices in individual markets. Please
contact your sales representative if you have questions about the
availability of products in your area.
Content ID: AP-017191
References
- Townshend, David, et al. Two to Five-Year Outcomes of Total
Ankle Arthroplasty with the Infinity Fixed-Bearing Implant: A
Concise Follow-up of a Previous Report. The Journal of Bone and
Joint Surgery. Vol. 105, no. 23, 6 Dec. 2023, pp. 1846-1856.
- Penner, et. al. The Infinity Total Ankle System Early Clinical
Results With 2- to 4-Year Follow-up, FAS 2018.
- Stryker’s 2023 sales data
- Hsu AR, Davis WH, Cohen BE, Jones CP, Ellington JK, Anderson
RB. Radiographic Outcomes of Preoperative CT Scan-Derived
Patient-Specific Total Ankle Arthroplasty. Foot Ankle Int. May 4
2015.
- Hamid KS, Matson AP, Nwachukwu BU, Scott DJ, Mather RC, 3rd,
DeOrio JK. Determining the Cost-Savings Threshold and Alignment
Accuracy of Patient-Specific Instrumentation in Total Ankle
Replacements. Foot Ankle Int. Jan 2017;38(1):49-57.
- Shippert, R. D. (2005). A Study of Time-Dependent Operating
Room Fees and How to save $100 000 by Using Time-Saving Products.
The American Journal of Cosmetic Surgery, 22(1), 25–34. Hamid KS,
Matson AP, Nwachukwu BU, Scott DJ, Mather RC, 3rd, DeOrio JK.
Determining the Cost-Savings Threshold and Alignment Accuracy of
Patient-Specific Instrumentation in Total Ankle Replacements. Foot
Ankle Int. Jan 2017;38(1):49-57.
- Anastasio, Albert, et al. Nationally Representative Trends in
Incidence of Procedures Done Concomitantly with Primary and
Revision Total Ankle From 2012 to 2020, Foot and Ankle Specialist,
2023.
* As of January, 2024
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240131382541/en/
Andrea Sampson President/CEO, Sampson Public Relations Group
asampson@sampsonprgroup.com 562.304.0301
Stryker (NYSE:SYK)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Stryker (NYSE:SYK)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024